Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
Sales 2015 | 347K 473K | Sales 2016 | 265K 362K | Capitalization | 1.58M 2.15M |
---|---|---|---|---|---|
Net income 2015 | -2M -2.73M | Net income 2016 | -1M -1.36M | EV / Sales 2015 | 8.29 x |
Net Debt 2015 | 255K 348K | Net Debt 2016 | 970K 1.32M | EV / Sales 2016 | 9.59 x |
P/E ratio 2015 |
-0.97
x | P/E ratio 2016 |
-1.13
x | Employees | 7 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 15-09-30 |
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.41K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ERGO Stock